Your browser doesn't support javascript.
loading
Generation, Transcriptomic States, and Clinical Relevance of CX3CR1+ CD8 T Cells in Melanoma.
Ishigaki, Hirohito; Yamauchi, Takayoshi; Long, Mark D; Hoki, Toshifumi; Yamamoto, Yuta; Oba, Takaaki; Ito, Fumito.
Affiliation
  • Ishigaki H; Department of Surgery, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California.
  • Yamauchi T; Division of Pathogenesis and Disease Regulation, Department of Pathology, Shiga University of Medical Science, Otsu, Japan.
  • Long MD; Department of Surgery, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California.
  • Hoki T; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Yamamoto Y; Department of Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Oba T; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Ito F; Oncology Science Unit, MSD Japan, Tokyo, Japan.
Cancer Res Commun ; 4(7): 1802-1814, 2024 Jul 01.
Article de En | MEDLINE | ID: mdl-38881188
ABSTRACT
Recent progress in single-cell profiling technologies has revealed significant phenotypic and transcriptional heterogeneity in tumor-infiltrating CD8+ T cells. However, the transition between the different states of intratumoral antigen-specific CD8+ T cells remains elusive. Here, we sought to examine the generation, transcriptomic states, and the clinical relevance of melanoma-infiltrating CD8+ T cells expressing a chemokine receptor and T-cell differentiation marker, CX3C chemokine receptor 1 (CX3CR1). Analysis of single-cell datasets revealed distinct human melanoma-infiltrating CD8+ T-cell clusters expressing genes associated with effector T-cell function but with distinguishing expression of CX3CR1 or PDCD1. No obvious impact of CX3CR1 expression in melanoma on the response to immune checkpoint inhibitor therapy was observed while increased pretreatment and on-treatment frequency of a CD8+ T-cell cluster expressing high levels of exhaustion markers was associated with poor response to the treatment. Adoptively transferred antigen-specific CX3CR1- CD8+ T cells differentiated into the CX3CR1+ subset in mice treated with FTY720, which inhibits lymphocyte egress from secondary lymphoid tissues, suggesting the intratumoral generation of CX3CR1+ CD8+ T cells rather than their trafficking from secondary lymphoid organs. Furthermore, analysis of adoptively transferred antigen-specific CD8+ T cells, in which the Cx3cr1 gene was replaced with a marker gene confirmed that CX3CR1+ CD8+ T cells could directly differentiate from the intratumoral CX3CR1- subset. These findings highlight that tumor antigen-specific CX3CR1- CD8+ T cells can fully differentiate outside the secondary lymphoid organs and generate CX3CR1+ CD8+ T cells in the tumor microenvironment, which are distinct from CD8+ T cells that express markers of exhaustion.

SIGNIFICANCE:

Intratumoral T cells are composed of heterogeneous subpopulations with various phenotypic and transcriptional states. This study illustrates the intratumoral generation of antigen-specific CX3CR1+ CD8+ T cells that exhibit distinct transcriptomic signatures and clinical relevance from CD8+ T cells expressing markers of exhaustion.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphocytes TIL / Lymphocytes T CD8/ / Transcriptome / Récepteur-1 de la chimiokine CX3C / Mélanome Limites: Animals / Humans Langue: En Journal: Cancer Res Commun Année: 2024 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphocytes TIL / Lymphocytes T CD8/ / Transcriptome / Récepteur-1 de la chimiokine CX3C / Mélanome Limites: Animals / Humans Langue: En Journal: Cancer Res Commun Année: 2024 Type de document: Article Pays de publication: États-Unis d'Amérique